Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Grant/Award of 220,000 KLRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Kailera Therapeutics, Inc. (KLRA) | Grant/Award | 220,000 | n/a |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Tender of Shares | 116,338 | n/a |
| Jan 30, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 45,220 | n/a |
| Jan 23, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 7,725 | $168.1K |
| Jan 21, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 2,203 | $43.6K |
| Jan 15, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 2,618 | $58.1K |
| Jun 11, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 82,500 | $1.60M |
| Jan 30, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 825 | $24.4K |
| Jan 23, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 3,948 | $120.1K |
| Jan 21, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Sale | 2,145 | $64.3K |